Join to View Full Profile
1400 Holcombe BlvdHouston, TX 77030
Phone+1 877-632-6789
Dr. Vokes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2016 - 2019- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2013 - 2016
Harvard Medical SchoolClass of 2013
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2022 - 2027
TN State Medical License 2022 - 2027
WA State Medical License 2022 - 2027
GA State Medical License 2022 - 2026
LA State Medical License 2022 - 2026
TX State Medical License 2020 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case Report.Bingnan Zhang, Komal B Shah, Mitchell Parma, Kaiwen Wang, Eric K Singhi
Journal of Thoracic Oncology. 2025-03-24 - Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial.Marcelo V Negrao, Alvaro G Paula, David Molkentine, Laura Hover, Monique Nilsson
Clinical Cancer Research. 2025-03-17 - 1 citationsAuthor Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun
Nature. 2025-03-01
Journal Articles
- Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid TumorsJeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
Lectures
- Distinct immunogenomic properties of melanomas with stable disease as best response to immune checkpoint blockade (ICB).2019 ASCO Annual Meeting - 6/1/2019
- Genomic correlates of response to immune checkpoint blockade in microsatellite stable solid tumors.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
MD Anderson Secures Nearly $23 Million in CPRIT Grants for Cancer Research and Faculty RecruitmentFebruary 19th, 2025
Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell CarcinomaFebruary 5th, 2021- Integrated Molecular Drivers Coordinate Biological and Clinical States in MelanomaNovember 23rd, 2020
- Join now to see all
Grant Support
- Integrated blood and radiomic subtyping to guide immunotherapy treatment selection and early response assessment in metastatic non-small cell lung cancerUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
